NewsRoom Articles - Page 171 of 619

WednesdayOct 19, 2022 4:20 pm

420 with CNW — Nationwide Survey Data Shows Majority of Americans Support Cannabis Policy Reform

We have seen interest in cannabis increase these last few years, with new survey data showing that some three of four Americans, including majorities of Democrats, Republicans and Independents, are in favor of changing marijuana’s classification under federal law. Currently, 37 states and the District of Columbia have legalized the medical use of marijuana while 19 states have legalized its recreational use. Despite this, cannabis remains classified under Schedule I of the federal Controlled Substances Act with harmful drugs such as heroin. Drugs under this categorization have no currently accepted medical use in treatment and are thought to have a…

WednesdayOct 19, 2022 12:00 pm

REZYFi, Inc. In Great Position as Efforts to Enrich Marijuana Jurisprudence Gain Steam

REZYFi is a mortgage origination and specialized financing company with a primary focus on providing senior loans and project financings to state-licensed operators in the cannabis industry The company operates through two wholly owned subsidiaries, REZYFi Lending and ResMac REZYFi is in a position to benefit from recent efforts by the Biden administration and the U.S. Congress to reschedule and decriminalize marijuana, respectively, with the moves expected to boost the cannabis industry The SAFE Banking Act of 2021 and MORE Act have passed the U.S. House of Representatives and are awaiting debate in the Senate; the two bills, if passed…

WednesdayOct 19, 2022 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Novel DehydraTECH(TM) Technology to Address Unmet Antihypertension Drug Market

Research has shown that co-occurring conditions may be linked to high blood pressure, including bone aging and mental illness The antihypertension drug market is anticipated to rise due to the launch of novel pharmaceuticals and diagnostic agents Valued at US $30.2 billion in 2021, the market is expected to grow at a CAGR of 3%, resulting in a value of US $40 billion by 2031 Lexaria’s patented DehydraTECH(TM) technology offers higher bioavailability of active pharmaceutical ingredients due to, in part, bypassing first-pass-liver processing, improving the speed of onset, and brain absorption The American Heart Association (“AMA”) refers to high blood…

WednesdayOct 19, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Building Portfolio of Brands that Resonates with End Consumers as It Targets Margins and Profitability

Flora Growth is a global cannabis company building a connected, design-led collective of plant-based wellness and lifestyle brands The company’s portfolio of brands is designed to deliver the most compelling customer experiences in the world Through its M&A strategy, Flora Growth has brought on board brands like JustCBD, Vessel Brands Inc., Masaya, No Cap Hemp Co., and Mambe Flora hopes to establish meaningful connections with consumers through these brands, which will enable it to increase its margins and profitability The cannabis industry has gone global, undergoing a sea change in commercialization, normalization, and liberalization. According to a report by New…

WednesdayOct 19, 2022 4:20 am

420 with CNW — Biden’s Orders on Marijuana Run into Catch-22

There was a flurry of reaction, most of it in support, when President Joseph Biden recently issued a directive instructing the Department of Health & Human Services (HHS) to carry out a thorough medical as well as scientific review assessing the appropriateness of the current classification of cannabis in the Controlled Substances Act of 1970. In that law, marijuana is categorized in the same highly restricted group with heroin, cocaine and LSD (ecstasy). As the dust settles and the real work gets underway, it will become abundantly clear how much of a catch-22 the review represents. Given that marijuana has…

TuesdayOct 18, 2022 4:20 pm

420 with CNW — Could President Biden Overhaul America’s Cannabis Policy?

Last week, President Joseph Biden announced that individuals convicted of simple cannabis possession under federal law would be pardoned of their convictions. This proclamation thrust the country’s marijuana policy into the limelight, with the president also urging governors to pardon those convicted of the same under state law. At the moment, marijuana is classified as a Schedule I substance under the Controlled Substances Act. All substances classified under this schedule are thought to have a high potential for abuse and no currently accepted medical use. Other substances under this schedule include LSD and heroin. This classification is difficult to understand,…

TuesdayOct 18, 2022 4:20 am

420 with CNW — Governors Across the US Weigh in on Biden’s Call for Mass Marijuana Pardons

President Joseph Biden recently announced mass pardons for people convicted in federal courts on minor marijuana possession charges. While making that announcement, he called on governors across the nation to emulate the federal action and replicate the clemency at state level. His call to action has elicited mixed reactions, and we capture the highlights below. Colorado governor Jared Polis revealed that the U.S. president had finally decided to walk the road that Colorado took two years earlier. He said that the action taken by the president would remove any roadblocks that were in the lives of the people affected by…

MondayOct 17, 2022 4:20 pm

420 with CNW — Study Finds Federal Cannabis Prohibition Is Exposing Patients to Tainted Products

New research has found that the ongoing prohibition of cannabis at the federal level is getting between safe products and consumers. The research was conducted for one year by investigators at Arizona State University, led by Dr. Maxwell Leung. The objective of the research was to determine the prevalence of a range of contaminants in lab-tested marijuana. Currently, marijuana is still classified as a Schedule I substance under the Controlled Substances Act, which means that it isn’t subject to USDA or FDA regulations that are applied to legal products. This ongoing prohibition has left many states to work out how…

MondayOct 17, 2022 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Drug Development Program Seeking to Provide Safe, Well-Tolerated, Effective Antihypertensive Medication Amid Continued Reports of Suboptimal Adherence to Existing Treatments

Lexaria Bioscience, a global innovator in drug delivery technology, has developed a potential treatment for hypertension using the company’s patented DehydraTECH(TM) platform, now shown in several human studies to reduce blood pressure and arterial stiffness Lexaria’s antihypertensive drug development program comes at a time when researchers are documenting poor control of hypertension among both men and women, partly due to suboptimal adherence to existing antihypertension medication Reasons advanced for the suboptimal adherence include lack of awareness or treatment, increased number of prescribed medications, and major adverse effects of the prescribed drugs Lexaria has so far shown that its DehydraTECH-CBD is…

MondayOct 17, 2022 9:00 am

Changing Legal Landscape for Cannabis in Colombia and the U.S. Portends a New Era of Productivity for Flora Growth Corp. (NASDAQ: FLGC)

Colombia and the United States have both recently exhibited new openness to the possibility of decriminalizing adult recreational cannabis use through legislative change Cannabis supplier Flora Growth cultivates its product at a key Colombian farm and provides it to international markets, and may see additional opportunities arise as cannabis policies advance in the two countries Flora Growth recently announced completion of its first shipments of high-CBD dried cannabis flower to Switzerland and the Czech Republic, as well as CBD isolate supplied to its market in the United States The company also recently reported a 604 percent YOY increase in revenues…

News and publishing service for cannabis related companies

Contact us: 512.354.7000